ClinicalTrials.gg
RecruitingNCT04726423Updated Jul 12, 2023

Chronic Pain and Transcranial Direct Current Stimulation in Clinical Settings

An observational study in Chronic Pain, sponsored by Université de Sherbrooke. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-12.

Sponsored by Université de Sherbrooke · Observational

How we know

From the registry’s dates

  • Started Jan 2021; still recruiting 5 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Chronic Pain by Université de Sherbrooke — 8 open to participants now, 9 under way, none of them phase 3. Chronic Pain · Université de Sherbrooke.

Started
2021
the only one that year
Observational
4 of 15
1 open now
Registered
6th of 15
by date

Among the 15 studies in Chronic Pain by Université de Sherbrooke, this one is the only one that started in 2021, is one of 4 observational ones, and was the 6th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

8 of the 15 studies in Chronic Pain by Université de Sherbrooke are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Chronic Pain by Université de Sherbrooke, or all of them as a file.
02

Study summary

Physical exercises and transcranial direct current stimulation (tDCS) are both known to reduce chronic pain in structured laboratory studies. The aim of this study is to assess the efficacy of this combined treatment in clinical settings.

Read the detailed description

Chronic pain patients who are going to the physiotherapy clinic to receive tDCS treatment sessions are evaluated in order to assess the efficacy of tDCS in clinical settings. Physiotherapists prescribe physical exercises adapted to the patients conditions. Patients performed their physical exercises every time they received a tDCS treatment, but were also recommended to continue their physical exercises program at home after completion of physiotherapy visits.

Concerning tDCS treatment, patients were encouraged to receive 1 tDCS session per day for 5 consecutive days.

03

Conditions studied

  • Chronic Pain

Keywords

  • transcranial direct current stimulation
  • physical exercise
  • physiotherapy
  • clinical settings
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients that received tDCS sessions in clinical settings

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • To have chronic pain

Exclusion criteria

Exclusion Criteria:

  • to tDCS
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes

Interventions

  • Othertranscranial direct current stimulation

    5 daily sessions of tDCS (2mA, 20 min) were recommended to all patients. Physical exercises were also done at the physiotherapy clinic. Physical exercises program was recommended to be continued at home after the week of physiotherapy visits.

    Also known as: tDCS

06

What researchers measure

Primary outcomes

  1. Change in McGill pain Questionnaire

    qualitative and quantitative aspects of pain

    Time frame: Baseline, 1 week, 1 month

  2. Change in Brief Pain Inventory

    Physical Function

    Time frame: Baseline, 1 week, 1 month

  3. Change in Tampa Questionnaire

    Kinesiophobia

    Time frame: Baseline, 1 week, 1 month

  4. Change in Beck Depression Inventory

    Depression

    Time frame: Baseline, 1 week, 1 month

  5. Change in Patient global impression of change

    Impression of change

    Time frame: 1 week, 1 month

Secondary outcomes

  1. Number of sessions received

    Feasibility; did the patients received all their tDCS sessions in 5 days (1 per day)

    Time frame: Through study completion, an average of 5 days

  2. Side effect

    Side effect reported by the patients (headache, dizziness, fatigue, nausea, redness, tingling)

    Time frame: Through study completion, an average of 5 days

07

Study locations

1 of 1 sites recruiting
  • Physio-Atlas
    Sherbrooke, Quebec J1L 0H8, Canada
    Recruiting
    • Antoine Laramé, M.Sc. · Contact819-562-0868
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2021 to primary completion in Feb 2021, 1 month.

Of 337 non-industry observational studies under Chronic Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 56. This study's 1 month is below that.

Counting every sponsor, half of 363 studies reached it within 24 months; a quarter within 12 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2021
First posted
Jan 27, 2021
StartActual
Jan 4, 2021
Primary completionActual
Feb 4, 2021
CompletionEst.
Dec 2023
Last update
Jul 12, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04726423
Responsible party
Guillaume Léonard (Professor, Université de Sherbrooke) — Principal investigator
First posted
Jan 27, 2021
Start date
Jan 4, 2021
Primary completion
Feb 4, 2021
Completion
Dec 2023 (estimated)
Last update
Jul 12, 2023

Study contacts

Guillaume Leonard, PhD
Contact
guillaume.leonard2@usherbrooke.ca
1 819-780-2220
Marie-Philippe Harvey, M.Sc
Contact
marie.philippe.harvey@usherbrooke.ca
Guillaume Leonard, PhD
principal investigator · Université de Sherbrooke

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion